What is Genetico?
Based in Russia, the Center for Genetics and Reproductive Medicine (Genetico) operates as a prominent medical laboratory. The company offers a comprehensive suite of genetic services tailored for both medical professionals and individual patients. Genetico's focus on advanced genetic diagnostics and reproductive medicine positions it as a key player in the healthcare technology landscape, leveraging its expertise to provide critical health insights and solutions.
How much funding has Genetico raised?
Genetico has raised a total of $2.2M across 1 funding round:
Stock Offering
$2.2M
Stock Issuance/Offering (2023): $2.2M, investors not publicly disclosed
What's next for Genetico?
The recent major strategic investment signals a pivotal growth phase for Genetico. This capital infusion is expected to fuel expansion initiatives, potentially including the enhancement of its service offerings, broader market penetration, and further investment in research and development. Genetico's trajectory suggests a strategic focus on solidifying its market leadership and exploring new frontiers in genetic and reproductive healthcare.
See full Genetico company page
